Abstract
Bartter syndrome is a group of inherited, salt-losing tubulopathies presenting as hypokalemic metabolic alkalosis with normotensive hyperreninemia and hyperaldosteronism. Around 150 cases have been reported in literature till now. Mutations leading to salt losing tubulopathies are not routinely tested in Indian population. The authors have done the genetic analysis for the first time in the Bartter syndrome on two cases from India. First case was antenatal Bartter syndrome presenting with massive polyuria and hyperkalemia. Mutational analysis revealed compound heterozygous mutations in KCNJ1(ROMK) gene [p(Leu220Phe), p(Thr191Pro)]. Second case had a phenotypic presentation of classical Bartter syndrome however, genetic analysis revealed only heterozygous novel mutation in SLC12A gene p(Ala232Thr). Bartter syndrome is a clinical diagnosis and genetic analysis is recommended for prognostication and genetic counseling.
References
Seyberth HW. An improved terminology and classification of Bartter like syndromes. Nat Clin Pract Nephrol. 2008;4:560–7.
Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis, a new clinical syndrome. Am J Med. 1962;33:811–28.
Sampathkumar K, Muralidharan U, Kannan A, Ramakrishnan M, Ajeshkumar R. Childhood Bartter’s syndrome: An Indian case series. Indian J Nephrol. 2010;20:207–10.
Amirlak I, Dawson KP. Bartter syndrome: An overview. Q J Med. 2000;93:207–15.
Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F, et al; Italian Collaborative Group for Bartter Syndrome. Long-term follow-up of patients with Bartter syndrome type I and II. Nephrol Dial Transplant. 2010;25:2976–81.
Vollmer M, Koehrer M, Topaloglu R, Strahm B, Omran H, Hildebrandt F. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome. Pediatr Nephrol. 1998;12:69–71.
Fremont OT, Chan JCM. Understanding Bartter syndrome and Gitelman syndrome. World J Pediatr. 2012;8:25–30.
Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus G, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112:183–90.
Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: Benefits and side effects of long-term treatment. Pediatr Nephrol. 2004;19:858–63.
Ataoglu E, Civilibal M, Ozkul AA, Varal IG, Oktay ER, Murat E. Indomethacin-induced colon perforation in Bartter’s syndrome. Indian J Pediatr. 2009;76:322–3.
Contributions
PKS and BS: Collected the data, prepared, critically revised and finally approved the manuscript; RS and KA: Collected the data, prepared the manuscript; PK and VKA: Critically revised and finally approved the manuscript; HC: Did the genetic analysis and provided the interpretation of the same. PK will act as guarantor for the paper.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, P.K., Saikia, B., Sharma, R. et al. Genetic Analysis in Bartter Syndrome from India. Indian J Pediatr 81, 1095–1098 (2014). https://doi.org/10.1007/s12098-014-1379-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1379-6